New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Pulmonx Corporation
LUNG
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

266M

Medical - Devices

Next Earning date - 04 Nov 2024

266M

Medical - Devices

Next Earning date - 04 Nov 2024

6.80USD
Shape-0.16 ( -2.30%)
favorite-chart

Relative Strenght

15
favorite-chart

Volume Buzz

-20%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

54%

Quote Panel

Shape
Updated October 17, 2024
1W 1.95 % 1M -19.05 % 3M -14.68 % 1Y -19.62 %

Key Metrics

Shape
  • Market Cap

    266.24M


  • Shares Outstanding

    39.15M


  • Share in Float

    35.39M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    6.8


  • Average Volume

    297445


  • Beta

    0.639


  • Range

    5.46-14.835


  • Industry

    Medical - Devices


  • Website

    https://pulmonx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.56x

P/S Ratio

2.68x

P/B Ratio

0.4

Debt/Equity

-75.6%

Net Margin

$-1.5

EPS

How LUNG compares to sector?

P/E Ratio

Relative Strength

Shape

LUNG

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$98M

Shape373%

2025-Revenue

$1.61

Shape-312%

2025-EPS

$84M

Shape-523%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Lake Street

initialise

Previous: Not converted

2024-06-04

Now: Buy

Wells Fargo

upgrade

Previous: Equal-Weight

2023-02-27

Now: Overweight

Citigroup

upgrade

Previous: Not converted

2022-12-12

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.38
vs -0.28

Q4.22

arrow
arrow

N/A

-0.38
vs -0.35

Q1.23

arrow
arrow

N/A

-0.42
vs -0.43

Q2.23

arrow
arrow

N/A

-0.43
vs -0.40

Q3.23

arrow
arrow

N/A

-0.39
vs -0.38

Q4.23

arrow
arrow

N/A

-0.36
vs -0.38

Q1.24

arrow
arrow

N/A

-0.36
vs -0.42

Q2.24

arrow
arrow

N/A

-0.39
vs -0.43

Q3.24

arrow
arrow

N/A

-0.45
vs -0.39

Q4.24

arrow
arrow

N/A

-0.47
vs -0.36

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+2%

13.5M  vs 13.3M

Q4.22

arrow
arrow

+13%

15.4M  vs 13.7M

Q1.23

arrow
arrow

+35%

14.5M  vs 10.8M

Q2.23

arrow
arrow

+23%

17.2M  vs 13.9M

Q3.23

arrow
arrow

+31%

17.7M  vs 13.5M

Q4.23

arrow
arrow

+25%

19.3M  vs 15.4M

Q1.24

arrow
arrow

+30%

18.9M  vs 14.5M

Q2.24

arrow
arrow

+21%

20.8M  vs 17.2M

Q3.24

arrow
arrow

+15%

20.3M  vs 17.7M

Q4.24

arrow
arrow

+18%

22.7M  vs 19.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.09

Q4.22

arrow
arrow

-9%

-0.09
vs -0.08

Q1.23

arrow
arrow

-11%

-0.11
vs -0.09

Q2.23

arrow
arrow

-12%

-0.12
vs -0.11

Q3.23

arrow
arrow

-12%

-0.12
vs -0.12

Q4.23

arrow
arrow

-12%

-0.12
vs -0.12

Q1.24

arrow
arrow

-12%

-0.12
vs -0.12

Q2.24

arrow
arrow

-15%

-0.15
vs -0.12

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

104

104
vs 105

-1%

Q4.22

arrow
arrow

119

119
vs 104

14%

Q1.23

arrow
arrow

113

113
vs 119

-5%

Q2.23

arrow
arrow

118

118
vs 113

4%

Q3.23

arrow
arrow

119

119
vs 118

1%

Q4.23

arrow
arrow

125

125
vs 119

5%

Q1.24

arrow
arrow

118

118
vs 125

-6%

Q2.24

arrow
arrow

109

109
vs 118

-8%

Earnings Growth

Latest News